{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:36:45Z","timestamp":1790073405218,"version":"4.0.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19 AI104209"],"award-info":[{"award-number":["U19 AI104209"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01 AI140498"],"award-info":[{"award-number":["U01 AI140498"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI140134"],"award-info":[{"award-number":["R01AI140134"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases"},{"DOI":"10.13039\/100016667","name":"The Sean N. Parker Center for Allergy and Asthma Research at Stanford University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016667","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>While food allergy oral immunotherapy (OIT) can provide safe and effective desensitization (DS), the immune mechanisms underlying development of sustained unresponsiveness (SU) following a period of avoidance are largely unknown. Here, we compare high dimensional phenotypes of innate and adaptive immune cell subsets of participants in a previously reported, phase 2 randomized, controlled, peanut OIT trial who achieved SU vs. DS (no vs. with allergic reactions upon food challenge after a withdrawal period; <jats:italic>n<\/jats:italic>\u2009=\u200921 vs. 30 respectively among total 120 intent-to-treat participants). Lower frequencies of na\u00efve CD8<jats:sup>+<\/jats:sup> T cells and terminally differentiated CD57<jats:sup>+<\/jats:sup>CD8<jats:sup>+<\/jats:sup> T cell subsets at baseline (pre-OIT) are associated with SU. Frequency of na\u00efve CD8<jats:sup>+<\/jats:sup> T cells shows a significant positive correlation with peanut-specific and Ara h 2-specific IgE levels at baseline. Higher frequencies of IL-4<jats:sup>+<\/jats:sup> and IFN\u03b3<jats:sup>+<\/jats:sup> CD4<jats:sup>+<\/jats:sup> T cells post-OIT are negatively correlated with SU. Our findings provide evidence that an immune signature consisting of certain CD8<jats:sup>+<\/jats:sup> T cell subset frequencies is potentially predictive of SU following OIT.<\/jats:p>","DOI":"10.1038\/s41467-022-34222-8","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T16:04:58Z","timestamp":1667577898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["CD8+ T cell differentiation status correlates with the feasibility of sustained unresponsiveness following oral immunotherapy"],"prefix":"10.1038","volume":"13","author":[{"given":"Abhinav","family":"Kaushik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Dunham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9058-3363","authenticated-orcid":false,"given":"Xiaorui","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3093-2568","authenticated-orcid":false,"given":"Sandra","family":"Andorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2855-4262","authenticated-orcid":false,"given":"Andrea","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie Elizabeth","family":"Kost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayantani B.","family":"Sindher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindy","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Tibshirani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0963-044X","authenticated-orcid":false,"given":"Scott D.","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holden T.","family":"Maecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5736-5340","authenticated-orcid":false,"given":"Stephen J.","family":"Galli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2467-4256","authenticated-orcid":false,"given":"R. Sharon","family":"Chinthrajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemarie H.","family":"DeKruyff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1869-2645","authenticated-orcid":false,"given":"Monali","family":"Manohar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2146-2955","authenticated-orcid":false,"given":"Kari C.","family":"Nadeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,4]]},"reference":[{"key":"34222_CR1","doi-asserted-by":"publisher","first-page":"100455","DOI":"10.1016\/j.waojou.2020.100455","volume":"13","author":"RS Chinthrajah","year":"2020","unstructured":"Chinthrajah, R. S. et al. Oral immunotherapy for peanut allergy: the pro argument. World Allergy Organ. J. 13, 100455 (2020).","journal-title":"World Allergy Organ. J."},{"key":"34222_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.iac.2019.09.005","volume":"40","author":"MLK Tang","year":"2020","unstructured":"Tang, M. L. K., Lozinsky, A. C. & Loke, P. Peanut oral immunotherapy: state of the art. Immunol. Allergy Clin. North Am. 40, 97\u2013110 (2020).","journal-title":"Immunol. Allergy Clin. North Am."},{"key":"34222_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-020-00908-6","volume":"20","author":"M Patrawala","year":"2020","unstructured":"Patrawala, M., Shih, J., Lee, G. & Vickery, B. Peanut oral immunotherapy: a current perspective. Curr. Allergy asthma Rep. 20, 14 (2020).","journal-title":"Curr. Allergy asthma Rep."},{"key":"34222_CR4","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nri.2016.111","volume":"16","author":"W Yu","year":"2016","unstructured":"Yu, W., Freeland, D. M. H. & Nadeau, K. C. Food allergy: immune mechanisms, diagnosis and immunotherapy. Nat. Rev. Immunol. 16, 751\u2013765 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"34222_CR5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jaci.2017.12.979","volume":"141","author":"MD Kulis","year":"2018","unstructured":"Kulis, M. D., Patil, S. U., Wambre, E. & Vickery, B. P. Immune mechanisms of oral immunotherapy. J. Allergy Clin. Immunol. 141, 491\u2013498 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"34222_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s12016-018-8680-5","volume":"55","author":"L Tordesillas","year":"2018","unstructured":"Tordesillas, L. & Berin, M. C. Mechanisms of oral tolerance. Clin. Rev. Allergy Immunol. 55, 107\u2013117 (2018).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"34222_CR7","doi-asserted-by":"publisher","first-page":"568598","DOI":"10.3389\/fimmu.2020.568598","volume":"11","author":"AM Schoos","year":"2020","unstructured":"Schoos, A. M. et al. Immunological outcomes of allergen-specific immunotherapy in food allergy. Front. Immunol. 11, 568598 (2020).","journal-title":"Front. Immunol."},{"key":"34222_CR8","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/S0140-6736(19)31793-3","volume":"394","author":"RS Chinthrajah","year":"2019","unstructured":"Chinthrajah, R. S. et al. Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study. Lancet (Lond., Engl.) 394, 1437\u20131449 (2019).","journal-title":"Lancet (Lond., Engl.)"},{"key":"34222_CR9","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/j.jaci.2019.01.011","volume":"143","author":"W Yu","year":"2019","unstructured":"Yu, W. et al. Allergen-specific CD8(+) T cells in peanut-allergic individuals. J. Allergy Clin. Immunol. 143, 1948\u20131952 (2019).","journal-title":"J. Allergy Clin. Immunol."},{"key":"34222_CR10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jaci.2020.07.032","volume":"147","author":"W Yu","year":"2021","unstructured":"Yu, W., Zhou, X., Lyu, S. C., Davis, M. M. & Nadeau, K. C. Regulation of peanut-specific CD8(+) T cells from nonallergic individuals. J. Allergy Clin. Immunol. 147, 385\u2013387.e381 (2021).","journal-title":"J. Allergy Clin. Immunol."},{"key":"34222_CR11","doi-asserted-by":"crossref","unstructured":"Zhou, X. et al. A positive feedback loop reinforces the allergic immune response in human peanut allergy. J. Exp. Med. 218, e20201793 (2021).","DOI":"10.1084\/jem.20201793"},{"key":"34222_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14919-4","volume":"11","author":"MR Neeland","year":"2020","unstructured":"Neeland, M. R. et al. Mass cytometry reveals cellular fingerprint associated with IgE+ peanut tolerance and allergy in early life. Nat. Commun. 11, 1091 (2020).","journal-title":"Nat. Commun."},{"key":"34222_CR13","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.jaci.2019.10.038","volume":"145","author":"M Tsai","year":"2020","unstructured":"Tsai, M., Mukai, K., Chinthrajah, R. S., Nadeau, K. C. & Galli, S. J. Sustained successful peanut oral immunotherapy associated with low basophil activation and peanut-specific IgE. J. Allergy Clin. Immunol. 145, 885\u2013896.e886 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"34222_CR14","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jaci.2013.11.007","volume":"133","author":"BP Vickery","year":"2014","unstructured":"Vickery, B. P. et al. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J. Allergy Clin. Immunol. 133, 468\u2013475 (2014).","journal-title":"J. Allergy Clin. Immunol."},{"key":"34222_CR15","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jaci.2018.10.028","volume":"143","author":"M Su\u00e1rez-Fari\u00f1as","year":"2019","unstructured":"Su\u00e1rez-Fari\u00f1as, M. et al. Predicting development of sustained unresponsiveness to milk oral immunotherapy using epitope-specific antibody binding profiles. J. Allergy Clin. Immunol. 143, 1038\u20131046 (2019).","journal-title":"J. Allergy Clin. Immunol."},{"key":"34222_CR16","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1152\/physrev.00023.2019","volume":"100","author":"A Ray","year":"2020","unstructured":"Ray, A., Camiolo, M., Fitzpatrick, A., Gauthier, M. & Wenzel, S. E. Are we meeting the promise of endotypes and precision medicine in asthma? Physiol. Rev. 100, 983\u20131017 (2020).","journal-title":"Physiol. Rev."},{"key":"34222_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jaci.2010.04.030","volume":"126","author":"K Blumchen","year":"2010","unstructured":"Blumchen, K. et al. Oral peanut immunotherapy in children with peanut anaphylaxis. J. Allergy Clin. Immunol. 126, 83\u201391.e81 (2010).","journal-title":"J. Allergy Clin. Immunol."},{"key":"34222_CR18","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.jaci.2013.12.1037","volume":"133","author":"A Syed","year":"2014","unstructured":"Syed, A. et al. Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3). J. Allergy Clin. Immunol. 133, 500\u2013510 (2014).","journal-title":"J. Allergy Clin. Immunol."},{"key":"34222_CR19","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.jaci.2014.11.005","volume":"135","author":"SD Narisety","year":"2015","unstructured":"Narisety, S. D. et al. A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy. J. Allergy Clin. Immunol. 135, 1275\u20131282 (2015). e1271\u20131276.","journal-title":"J. Allergy Clin. Immunol."},{"key":"34222_CR20","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jaci.2016.05.027","volume":"139","author":"BP Vickery","year":"2017","unstructured":"Vickery, B. P. et al. Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective. J. Allergy Clin. Immunol. 139, 173\u2013181.e178 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"34222_CR21","doi-asserted-by":"crossref","unstructured":"Monian, B. et al. Peanut oral immunotherapy differentially suppresses clonally distinct subsets of T helper cells. J. Clin. Invest. 132, e150634 (2022).","DOI":"10.1172\/JCI150634"},{"key":"34222_CR22","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1097\/ACI.0000000000000216","volume":"15","author":"E Wambre","year":"2015","unstructured":"Wambre, E. Effect of allergen-specific immunotherapy on CD4+ T cells. Curr. Opin. Allergy Clin. Immunol. 15, 581\u2013587 (2015).","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"34222_CR23","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.immuni.2006.06.011","volume":"25","author":"S Devadas","year":"2006","unstructured":"Devadas, S. et al. Granzyme B is critical for T cell receptor-induced cell death of type 2 helper T cells. Immunity 25, 237\u2013247 (2006).","journal-title":"Immunity"},{"key":"34222_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4049\/jimmunol.176.1.97","volume":"176","author":"V Sharma","year":"2006","unstructured":"Sharma, V., Delgado, M. & Ganea, D. Granzyme B, a new player in activation-induced cell death, is down-regulated by vasoactive intestinal peptide in Th2 but not Th1 effectors. J. Immunol. (Baltim., Md.: 1950) 176, 97\u2013110 (2006).","journal-title":"J. Immunol. (Baltim., Md.: 1950)"},{"key":"34222_CR25","doi-asserted-by":"crossref","unstructured":"Zhou, X. et al. Targeted DNA methylation profiling reveals epigenetic signatures in peanut allergy. JCI Insight 6, e143058 (2021).","DOI":"10.1172\/jci.insight.143058"},{"key":"34222_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/cyto.a.22351","volume":"85","author":"A Larbi","year":"2014","unstructured":"Larbi, A. & Fulop, T. From \u201ctruly na\u00efve\u201d to \u201cexhausted senescent\u201d T cells: when markers predict functionality. Cytometry A 85, 25\u201335 (2014).","journal-title":"Cytometry A"},{"key":"34222_CR27","doi-asserted-by":"crossref","unstructured":"Wambre, E. et al. A phenotypically and functionally distinct human TH2 cell subpopulation is associated with allergic disorders. Sci. Transl. Med. 9, eaam9171 (2017).","DOI":"10.1126\/scitranslmed.aam9171"},{"key":"34222_CR28","doi-asserted-by":"crossref","unstructured":"Gowthaman, U. et al. Identification of a T follicular helper cell subset that drives anaphylactic IgE. Science (New York, N.Y.) 365, eaaw6433 (2019).","DOI":"10.1126\/science.aaw6433"},{"key":"34222_CR29","doi-asserted-by":"crossref","unstructured":"Kaushik, A. et al. CyAnno: a semi-automated approach for cell type annotation of mass cytometry datasets. Bioinformatics (Oxford, England) 37, 4164\u20134171 (2021).","DOI":"10.1093\/bioinformatics\/btab409"},{"key":"34222_CR30","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1111\/all.14833","volume":"76","author":"M Manohar","year":"2021","unstructured":"Manohar, M. et al. Immune changes beyond Th2 pathways during rapid multifood immunotherapy enabled with omalizumab. Allergy 76, 2809\u20132826 (2021).","journal-title":"Allergy"},{"key":"34222_CR31","first-page":"8187","volume":"15","author":"Y Yu","year":"2018","unstructured":"Yu, Y. et al. Recent advances in CD8(+) regulatory T cell research. Oncol. Lett. 15, 8187\u20138194 (2018).","journal-title":"Oncol. Lett."},{"key":"34222_CR32","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.jaci.2019.07.022","volume":"144","author":"EW Gelfand","year":"2019","unstructured":"Gelfand, E. W. & Hinks, T. S. C. Is there a role for type 2 CD8(+) T cells in patients with steroid-resistant asthma? J. Allergy Clin. Immunol. 144, 648\u2013650 (2019).","journal-title":"J. Allergy Clin. Immunol."},{"key":"34222_CR33","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/cyto.a.22625","volume":"87","author":"S Van Gassen","year":"2015","unstructured":"Van Gassen, S. et al. FlowSOM: using self\u2010organizing maps for visualization and interpretation of cytometry data. Cytom. Part A 87, 636\u2013645 (2015).","journal-title":"Cytom. Part A"},{"key":"34222_CR34","unstructured":"Hahne, F. flowStats: Statistical methods for the analysis of flow cytometry data. (2022). http:\/\/www.github.com\/RGLab\/flowStats."},{"key":"34222_CR35","unstructured":"Kolde, R. pheatmap: Pretty Heatmaps. (2019). https:\/\/cran.rproject.org\/web\/packages\/pheatmap\/index.html."},{"key":"34222_CR36","unstructured":"Wickham, H., Chang, W. & Wickham, M. H. Package \u2018ggplot2\u2019. Create Elegant Data Visualisations Using the Grammar of Graphics. Version 2, 1\u2013189 (2016)."},{"key":"34222_CR37","doi-asserted-by":"crossref","unstructured":"McInnes, L., Healy, J. & Melville, J. Umap: uniform manifold approximation and projection for dimension reduction. Preprint at arXiv:1802.03426 (2018).","DOI":"10.21105\/joss.00861"},{"key":"34222_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v082.i13","volume":"82","author":"A Kuznetsova","year":"2017","unstructured":"Kuznetsova, A., Brockhoff, P. B. & Christensen, R. H. lmerTest package: tests in linear mixed effects models. J. Stat. Softw. 82, 1\u201326 (2017).","journal-title":"J. Stat. Softw."},{"key":"34222_CR39","unstructured":"Kassambara, A. rstatix: pipe-friendly framework for basic statistical tests. (2020). https:\/\/cran.rproject.org\/web\/packages\/rstatix\/index.html."},{"key":"34222_CR40","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.21105\/joss.02763","volume":"5","author":"K Goldfeld","year":"2020","unstructured":"Goldfeld, K. & Wujciak-Jens, J. simstudy: Illuminating research methods through data generation. J. Open Source Softw. 5, 2763 (2020).","journal-title":"J. Open Source Softw."},{"key":"34222_CR41","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1467-9868.2005.00503.x","volume":"67","author":"H Zou","year":"2005","unstructured":"Zou, H. & Hastie, T. Regularization and variable selection via the elastic net. J. R. Stat. Soc.: Ser. B (Stat. Methodol.) 67, 301\u2013320 (2005).","journal-title":"J. R. Stat. Soc.: Ser. B (Stat. Methodol.)"},{"key":"34222_CR42","doi-asserted-by":"crossref","unstructured":"Friedman, J., Hastie, T. & Tibshirani, R. Regularization Paths for Generalized Linear Models via Coordinate Descent. J Stat Softw. 33, 1\u201322 (2010).","DOI":"10.18637\/jss.v033.i01"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34222-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34222-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34222-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T16:23:28Z","timestamp":1667579008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34222-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,4]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["34222"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-34222-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,4]]},"assertion":[{"value":"2 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.C.N. reports grants from National Institute of Allergy and Infectious Diseases (NIAID), National Heart, Lung, and Blood Institute (NHLBI), National Institute of Environmental Health Sciences (NIEHS), and Food Allergy Research & Education (FARE); stock options from IgGenix, Seed Health, ClostraBio, and ImmuneID; is a Director of World Allergy Organization (WAO), Advisor at Cour Pharma, Consultant for Excellergy, Red tree ventures, Eli Lilly, and Phylaxis, Co-founder of Before Brands, Alladapt, Latitude, and IgGenix; and National Scientific Committee member at Immune Tolerance Network (ITN), and National Institutes of Health (NIH) clinical research centers, outside the submitted work; patents include, \u201cMixed allergen composition and methods for using the same\u201d, \u201cGranulocyte-based methods for detecting and monitoring immune system disorders\u201d, \u201cMethods and Assays for Detecting and Quantifying Pure Subpopulations of White Blood Cells in Immune System Disorders,\u201d and \u201cMethods of isolating allergen-specific antibodies from humans and uses thereof\u201d. R.S.C. reports grants from NIAID, CoFAR, Aimmune, DBV Technologies, Astellas, Regeneron, Stanford Maternal and Child Health Research Institute (MCHRI), and FARE. She is an Advisory Board Member at Alladapt Therapeutics, Novartis, Genentech, Sanofi, Allergenis, and Nutricia. S.B.S. reports grants from NIH, Regeneron, DBV, AIMMUNE, Novartis, CoFAR, and FARE. She receives personal fees from Astra Zeneca, DBV, and honoraria from FARE. S.J.G. reports grants from the NIH. S.D.B. has consulted for Regeneron, Sanofi and Novartis on topics unrelated to this study, owns shares in AbCellera, has patents awarded or submitted related to immunoglobulin gene and protein analysis, and reports grants from the NIH. S.A. reports grants from the NIH. All others authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6646"}}